Skip to content
Open access

The HIV care continuum and determinants of antiretroviral therapy initiation among transgender women in France (1997–2023): a longitudinal cohort study

Aug 2026 · The Lancet Regional Health - Europe · Vol 69, pp. 101820 · 0 citations · 37 references
Medicine

TL;DR

Despite major improvements in the HIV care continuum for TWH in France, including faster ART initiation and viral suppression reaching UNAIDS 95% targets in 2013–2023, disparities by geographic origin have emerged, showing a delay in ART initiation among foreign-born TWH.

Abstract

Summary Background Studies on transgender women living with HIV (TWH) are scarce in Europe. We aimed to describe TWH and their care continuum during years 1997–2023 in France, focusing on determinants of time to antiretroviral therapy (ART) initiation. Methods In this longitudinal cohort study, we included treatment-naïve TWH with immuno-virological data from the ANRS CO4 French Hospital Database on HIV (FHDH). HIV care continuum outcomes, ART and viral suppression rates, and time intervals between HIV diagnosis, ART initiation, and viral suppression, were analyzed across three calendar periods (1997–2004, 2005–2012, and 2013–2023). Factors associated with time to ART initiation were assessed for each period using Cox models adjusted for age, geographic origin, year and region of enrollment, time between diagnosis and enrollment, and baseline immuno-virological status. Findings 801 TWH entered care between January 1, 1997 and December 31, 2023, mostly originating from Latin America (65%, 522/801), with a median age of 31 years [IQR, 27–36]. Between 1997–2004 and 2013–2023, time to ART initiation after entering care decreased from 3.9 [0–31] to 0.5 [0.2–1.2] months. More advanced HIV disease was associated with faster ART initiation until 2012 (hazard ratio [HR]: 3.17, 95% CI 2.14–4.68 for CD4 <200/mm3 or AIDS in 2005–2012). In 2013–2023, baseline viral load ≥100,000 was associated with faster ART initiation (HR: 1.45, 95% CI 1.14–1.86), whereas originating from Latin America (HR: 0.68, 95% CI 0.50–0.91) or other countries outside France (HR: 0.65, 95% CI 0.45–0.95) was associated with delayed ART initiation. Time to viral suppression after ART initiation decreased from 6.2 [3.0–27.9] in 1997–2004 to 2.3 [1.1–5.7] months in 2013–2023. Over the same periods, TWH on ART with viral suppression increased from 74.7% (109/146) to 95.5% (315/330). Interpretation Despite major improvements in the HIV care continuum for TWH in France, including faster ART initiation and viral suppression reaching UNAIDS 95% targets in 2013–2023, disparities by geographic origin have emerged, showing a delay in ART initiation among foreign-born TWH. Given that most TWH are foreign-born, targeted strategies and policies are needed to ensure equitable and timely access to HIV care. Funding ANRS-MIE and INSERM.

Read PDF

Similar papers

Review Open access Aug 2026

Factors associated with viral suppression and antiretroviral therapy adherence among adolescents and young adults living with HIV in the African Cohort Study

Viral suppression and ART adherence were high among AYLHIV in AFRICOS and clinic site and ART regimen were associated with outcomes, highlighting the importance of health system factors.

M. Brault, Aima A. Ahonkhai, Seth Frndak et al. · 0 citations
Open access Sep 2026

Clinical Characteristics, Healthcare Utilization, and Treatment Patterns Among People Living with HIV by Antiretroviral Therapy Use in the USA, 2021–2024

Despite advances in antiretroviral therapy (ART), real-world data remain limited regarding clinical characteristics and healthcare utilization according to ART use among people living with human immunodeficiency virus (PLWH), as well as patterns of ART use in this population. This retrospective cohort study used a US h...

M. Ramgopal, J. Lalezari, C. Huisingh et al. · 0 citations
Open access Jan 2026

Factors Associated With Viral Load Suppression Among Adolescents and Young Adults Living With HIV on ART in Rwanda: Data From Rwanda HIV Case‐Based Surveillance, 2019–2025

VLS among AYALHIV aged 15–24 years engaged in Rwanda's HIV care program is high, exceeding the UNAIDS 95% target, and country HIV programs should prioritize adherence‐focused interventions and proactively address underlying barriers to adherence in order to sustain optimal treatment outcomes.

G. Rwibasira, Jean Claude Kwizera, S. Karera et al. · 0 citations
Open access Sep 2026

HIV diagnosis and treatment status in individuals dying from HIV in Zimbabwe, Malawi, and South Africa: A model comparison analysis

Background Antiretroviral therapy (ART) has greatly reduced HIV-related mortality and improved life expectancy in sub-Saharan Africa since the early 2000s. However, HIV-related mortality remains high. To guide intervention priorities, we used seven established HIV simulation models to identify where in the HIV care cas...

L. Bansi-Matharu, Daniel T. Citron, R. Martin-Hughes et al. · 0 citations
Open access Sep 2026

Viral load suppression trends among young people with perinatally-acquired HIV on long-term antiretroviral therapy in Ndwedwe Local Municipality, South Africa.

Young people with perinatally acquired HIV (YPpHIV) in rural South Africa face persistent challenges in achieving and sustaining viral load (VL) suppression despite long-term antiretroviral therapy (ART). We conducted a retrospective cohort study using routinely collected TIER.Net data from eight primary healthcare fac...

Silindile Mncwango, N. Mbatha, T. Rossouw et al. · 0 citations
Review Open access Aug 2026

An audit assessing data quality, viral suppression, and transition to dolutegravir among children and adolescents with HIV in care at eThekwini Municipality, South Africa

Background The 2023 South African antiretroviral therapy (ART) guidelines recommend dolutegravir-based ART for children and adolescents with HIV (CAWH) >4 weeks old, including transition to dolutegravir-based ART if previously taking another regimen. Objectives We audited uptake of dolutegravir-based ART, viral load (V...

M. Hlabisa, L. Mtila, N. Lushaba et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.